Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 853

1.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ.

Blood. 2003 Mar 1;101(5):2015-23. Epub 2002 Oct 10.

PMID:
12393427
[PubMed - indexed for MEDLINE]
Free Article
2.

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.

Krishnan A, Bhatia S, Slovak ML, Arber DA, Niland JC, Nademanee A, Fung H, Bhatia R, Kashyap A, Molina A, O'Donnell MR, Parker PA, Sniecinski I, Snyder DS, Spielberger R, Stein A, Forman SJ.

Blood. 2000 Mar 1;95(5):1588-93.

PMID:
10688812
[PubMed - indexed for MEDLINE]
Free Article
3.

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC.

Br J Cancer. 1999 Oct;81(3):476-83.

PMID:
10507773
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.

Haematologica. 1998 Sep;83(9):812-23.

PMID:
9825578
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.

Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, et al.

J Clin Oncol. 1994 Dec;12(12):2527-34.

PMID:
7989926
[PubMed - indexed for MEDLINE]
7.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, K├Ârbling M, Martin T, Ueno NT, Champlin RE, Khouri IF.

Ann Oncol. 2002 Mar;13(3):450-9.

PMID:
11996478
[PubMed - indexed for MEDLINE]
Free Article
8.

Risk of leukemia following treatment for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM, et al.

J Natl Cancer Inst. 1994 Oct 5;86(19):1450-7.

PMID:
8089863
[PubMed - indexed for MEDLINE]
9.

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al.

J Clin Oncol. 1994 Dec;12(12):2535-42.

PMID:
7989927
[PubMed - indexed for MEDLINE]
10.

Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.

Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B.

J Clin Oncol. 2006 Aug 1;24(22):3604-10.

PMID:
16877727
[PubMed - indexed for MEDLINE]
Free Article
11.

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group.

J Clin Oncol. 2003 Sep 15;21(18):3440-6. Epub 2003 Mar 7.

PMID:
12668650
[PubMed - indexed for MEDLINE]
12.

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.

Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C.

J Cancer Res Clin Oncol. 1998;124(3-4):207-14. Review.

PMID:
9619748
[PubMed - indexed for MEDLINE]
13.

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.

Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.

Eur J Haematol. 2000 Jul;65(1):17-22.

PMID:
10914935
[PubMed - indexed for MEDLINE]
14.

Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.

Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD Jr.

J Clin Oncol. 1996 Feb;14(2):565-71.

PMID:
8636772
[PubMed - indexed for MEDLINE]
15.

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

Pedersen-Bjergaard J, Andersen MK, Christiansen DH.

Blood. 2000 Jun 1;95(11):3273-9. Review. Erratum in: Blood 2000 Sep 1;96(5):1680.

PMID:
10828005
[PubMed - indexed for MEDLINE]
Free Article
16.

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.

Howe R, Micallef IN, Inwards DJ, Ansell SM, Dewald GW, Dispenzieri A, Gastineau DA, Gertz MA, Geyer SM, Hanson CA, Lacy MQ, Tefferi A, Litzow MR.

Bone Marrow Transplant. 2003 Aug;32(3):317-24.

PMID:
12858205
[PubMed - indexed for MEDLINE]
17.
18.

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS.

J Clin Oncol. 2005 Apr 1;23(10):2208-14. Epub 2005 Mar 7.

PMID:
15753460
[PubMed - indexed for MEDLINE]
Free Article
19.

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.

Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R, Bernstein ID.

Blood. 1999 Aug 15;94(4):1237-47.

PMID:
10438711
[PubMed - indexed for MEDLINE]
Free Article
20.

Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JI, Orchard K, Towlson KE, Pearce RM, Marks DI; BSBMT Clinical Trials Committee.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1310-7.

PMID:
17162213
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk